Reska Biotech Stock

Reska Biotech Current Assets

The Current Assets of Reska Biotech (GWIN) as of Aug 23, 2026 is 300.00 USD. In the previous year, Current Assets was 300.00 USD — a change of 0.00% (lower).

Current Assets

300.00USD

YoY

0.00%

Last updated:

Current Assets of Reska Biotech is 2026 300.00 USD. Current Assets of Reska Biotech was 2025 300.00 USD. It decreases by 0.00% lower compared to the previous year.

The Reska Biotech Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2011
1,300.00 USD
Jan 1, 2012
9,200.00 USD
Jan 1, 2013
0.00 USD
Jan 1, 2014
0.00 USD
Jan 1, 2015
3.42 M USD
Jan 1, 2016
300.00 USD
Jan 1, 2017
300.00 USD
The Reska Biotech Current Assets history
YEARCurrent AssetsYoY
300.00USD0.00%
300.00USD-99.99%
3.42 MUSD
0.00USD
0.00USD-100.00%
9,200.00USD+607.69%
1,300.00USD
Access this data via the Eulerpool API

Reska Biotech Stock analysis

What does Reska Biotech do? The Glorywin Entertainment Group Inc is a Hong Kong-based company that specializes in the production, management, and marketing of entertainment content. The company was founded in 2005 and has been listed on the Canadian stock exchange since 2015. Glorywin's business model is based on the production and marketing of entertainment content in various sectors. This includes film and television production, music labels, event management, as well as the management and marketing of artists and celebrities. Over the years, the company has developed and produced a variety of products. In the film and television sector, these include TV series such as "The Four Detective Guards," "Journey to the East," "Ten Deadly Sins," and "Saviors in the Forbidden City." In addition, Glorywin has also produced films for the cinema such as "The Four," "Kung Fu Angels," and "The White Storm." Musically, the company is primarily active in the Asian pop industry and operates its own label with well-known artists such as Coco Lee and Janice Vidal. Another important business area for Glorywin is event management. The company organizes concerts, festivals, and other events in China and other Asian countries. The most well-known events include the "MTV Super Summit," the "Pepsi Music Festival," and the "Hong Kong Asian-Pop Music Festival." Glorywin often collaborates with other companies to reach a wider audience. In addition to the production of entertainment content and event management, Glorywin also operates its own leisure facilities. The goal is to make the brand and products of the company accessible to a broader audience. The company primarily focuses on theme parks and interactive museums. Currently, Glorywin operates the "Three Kingdoms City" theme park in China and the "Cool & Ice World" museum in Hong Kong. In recent years, the company has also focused on the digital media sector. Glorywin operates its own social media platform for fans and has developed a chatbot system for interactive communication with customers. The goal is to position and market the brand and products even more strongly in the digital world. To coordinate and manage all these activities, Glorywin has built an experienced team of managers and producers. The company works closely with international partners and collaborators to develop innovative products and events that excite the audience and tap into new markets. Overall, the company has become an important player in the Asian entertainment industry in recent years and has achieved numerous successes. This success is supported by the increasing popularity of Asian pop music, TV series, and films worldwide. In the future, Glorywin will likely continue to focus on these trends and attempt to establish itself in new markets. Reska Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Reska Biotech stock

Current Assets of Reska Biotech is 300.00 USD in 2026.

Current Assets of Reska Biotech changed from 300.00 USD to 300.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Reska Biotech since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Reska Biotech historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Reska Biotech

All Key Metrics — Reska Biotech